CH390916A - Verfahren zur Herstellung von pharmakologisch wirksamen organischen Verbindungen - Google Patents

Verfahren zur Herstellung von pharmakologisch wirksamen organischen Verbindungen

Info

Publication number
CH390916A
CH390916A CH7787759A CH7787759A CH390916A CH 390916 A CH390916 A CH 390916A CH 7787759 A CH7787759 A CH 7787759A CH 7787759 A CH7787759 A CH 7787759A CH 390916 A CH390916 A CH 390916A
Authority
CH
Switzerland
Prior art keywords
preparation
organic compounds
pharmacologically active
active organic
pharmacologically
Prior art date
Application number
CH7787759A
Other languages
English (en)
Inventor
D Lunsford Carl
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of CH390916A publication Critical patent/CH390916A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
CH7787759A 1959-06-19 1959-09-05 Verfahren zur Herstellung von pharmakologisch wirksamen organischen Verbindungen CH390916A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US821357A US3062827A (en) 1959-06-19 1959-06-19 5-(3', 5'-dialkylphenoxymethyl)-2-oxazolidones

Publications (1)

Publication Number Publication Date
CH390916A true CH390916A (de) 1965-04-30

Family

ID=25233163

Family Applications (2)

Application Number Title Priority Date Filing Date
CH7787759A CH390916A (de) 1959-06-19 1959-09-05 Verfahren zur Herstellung von pharmakologisch wirksamen organischen Verbindungen
CH602564A CH414640A (de) 1959-06-19 1959-09-05 Verfahren zur Herstellung von pharmakologisch wirksamen organischen Verbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH602564A CH414640A (de) 1959-06-19 1959-09-05 Verfahren zur Herstellung von pharmakologisch wirksamen organischen Verbindungen

Country Status (6)

Country Link
US (1) US3062827A (de)
BE (1) BE592006A (de)
CH (2) CH390916A (de)
DE (1) DE1163328B (de)
DK (1) DK121709B (de)
GB (1) GB888594A (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3251836A (en) * 1961-09-26 1966-05-17 Szabo Hnos Kessler & Cia S R L Oxazolidone derivatives and their preparation
US3331850A (en) * 1964-05-13 1967-07-18 Upjohn Co 5-(aryloxymethyl)-2-oxazolidinethiones
US4062862A (en) * 1975-07-04 1977-12-13 Nippon Chemiphar Co., Ltd. 5-Benzyl-2-oxazolidone derivatives and a process for producing the same
US6407128B1 (en) 2001-12-03 2002-06-18 Elan Pharmaceuticals, Inc. Method for increasing the bioavailability of metaxalone
US7714006B1 (en) 2001-12-03 2010-05-11 King Pharmaceuticals Research & Development, Inc. Methods of modifying the bioavailability of metaxalone
US7148364B2 (en) * 2002-01-07 2006-12-12 Sun Pharmaceutical Industries Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile
WO2003061552A2 (en) * 2002-01-14 2003-07-31 Sun Pharmaceutical Industries Limited Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone
US6562980B1 (en) 2002-08-19 2003-05-13 Yung Shin Pharma Ind. Co., Ltd. Method for producing 5-aryloxymethyl-2-oxazolidinones
WO2004019937A1 (en) * 2002-09-02 2004-03-11 Sun Pharmaceutical Industries Limited Pharmaceutical composition of metaxalone with enhanced oral bioavailability
WO2006082597A2 (en) * 2005-01-24 2006-08-10 Fdc Limited Crystal modification of 5-substituted-2-oxazoiidone derivative and its process thereof
US20070088065A1 (en) * 2005-10-14 2007-04-19 Jie Du Metaxalone products, method of manufacture, and method of use
US20080292584A1 (en) * 2005-10-14 2008-11-27 Mutual Pharmaceutical Company, Inc. Metaxalone products, method of manufacture, and method of use
WO2007074477A2 (en) * 2005-12-29 2007-07-05 Dabur Pharma Limited Metaxalone polymorphs
WO2008006096A1 (en) * 2006-07-07 2008-01-10 Boehringer Ingelheim Chemicals, Inc. Metaxalone synthesis
WO2009085637A1 (en) * 2007-12-21 2009-07-09 Url Pharma, Inc. Amorphous metaxalone and amorphous dispersions thereof
WO2009132119A2 (en) * 2008-04-25 2009-10-29 Auspex Pharmaceuticals, Inc. Substituted oxazolidinones
US8871793B2 (en) 2009-12-23 2014-10-28 Nuformix Limited Metaxalone cocrystals
US11918559B2 (en) 2019-06-25 2024-03-05 Primus Pharmceuticals, Inc. Reduced dose metaxalone formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437390A (en) * 1948-03-09 Z-oxazolidone compounds and proc
US2617825A (en) * 1948-06-04 1952-11-11 Givaudan Corp Process for preparation of salts of 1-amino-2-haloethanes
DE883902C (de) * 1951-03-02 1953-07-23 Basf Ag Verfahren zur Herstellung von cyclischen Urethanen
DE917972C (de) * 1951-03-02 1954-09-16 Basf Ag Verfahren zur Herstellung von cyclischen Urethanen
US2770649A (en) * 1955-06-22 1956-11-13 Robins Co Inc A H o-methoxyphenoxy-2-hydroxy-propyl carbamates
US2895960A (en) * 1958-06-26 1959-07-21 Robins Co Inc A H Method of production of 5-o-methoxyphenoxymethyl-2-oxazolidone

Also Published As

Publication number Publication date
GB888594A (en) 1962-01-31
DE1163328B (de) 1964-02-20
CH414640A (de) 1966-06-15
DK121709B (da) 1971-11-22
BE592006A (fr) 1960-12-19
US3062827A (en) 1962-11-06

Similar Documents

Publication Publication Date Title
CH379515A (de) Verfahren zur Herstellung von organischen Perhydratverbindungen
CH416617A (de) Verfahren zur Herstellung von organischen siliciumhaltigen Verbindungen
CH433253A (de) Verfahren zur Herstellung von organischen Isocyanatverbindungen
CH414640A (de) Verfahren zur Herstellung von pharmakologisch wirksamen organischen Verbindungen
CH385224A (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
CH395629A (de) Verfahren zur Formulierung biologisch wirksamer Verbindungen
CH400184A (de) Verfahren zur Herstellung von heterocyclischen Verbindungen
CH395119A (de) Verfahren zur Herstellung von heterocyclischen Verbindungen
CH422779A (de) Verfahren zur Herstellung von organischen Zinnverbindungen
CH390255A (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
CH377825A (de) Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
CH372673A (de) Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
CH410941A (de) Verfahren zur Herstellung von organischen Phosphorthioverbindungen
CH412851A (de) Verfahren zur Herstellung von parasitizid wirkenden Aminophenylmethylcarbamaten
CH427832A (de) Verfahren zur Herstellung von organischen Stickstoffverbindungen
CH372307A (de) Verfahren zur Herstellung von fluoreszierenden Verbindungen
CH375360A (de) Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
AT221235B (de) Verfahren zur Herstellung von organischen pentacyclischen Verbindungen
CH378883A (de) Verfahren zur Herstellung pharmazeutisch wirksamer Verbindungen
CH384589A (de) Verfahren zur Herstellung von heterocyclischen Verbindungen
CH379506A (de) Verfahren zur Herstellung von heterocyclischen Verbindungen
CH375015A (de) Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
CH366541A (de) Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
CH392514A (de) Verfahren zur Herstellung von neuen pharmakologisch wirksamen Verbindungen
CH383997A (de) Verfahren zur Herstellung von neuen basischen Verbindungen